Feb.01 -- U.S. Health & Human Services Secretary Alex Azar discusses President Donald Trump's proposal targeting rebates to pharmacy benefit managers in an effort to lower prescription drug prices. He speaks with Bloomberg's David Westin on "Bloomberg Markets: Balance of Power."
- Trump's Drug Pricing Plan Explained By HHS Secretary Azar ( Download)
- HHS Secretary Alex Azar On President Donald Trump's Drug Price Plans | CNBC ( Download)
- HHS Sec Azar on Trump's transparency drug pricing plan ( Download)
- HHS secretary Alex Azar on Trump's executive order to make drug pricing transparent ( Download)
- HHS Secretary Azar: Trump's drug prices proposal is better than campaign pledge ( Download)
- HHS Secretary on Trump's plan to rein in drug prices ( Download)
- HHS secretary on Medicare drug pricing, gender definitions ( Download)
- HHS Sec. Alex Azar on 'complete rewiring' of the drug pricing system in America ( Download)
- HHS 'a Azar Says Trump Drug Plan Won't Hurt Pharma R&D ( Download)
- HHS Secretary on the pressure on pharma to rein in drug prices ( Download)
- Trump, Azar Talk Prescription Drug Price Reform ( Download)
- Trump will not stop until the list prices of drugs comes down: HHS Secretary Alex Azar ( Download)
- HHS Secretary: Americans will get more affordable drug prices ( Download)
- Watch CNBC's full interview with HHS Secretary Alex Azar on controlling drug prices ( Download)
- Trump administration takes on high drug prices ( Download)
